Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100319772 | 10031977 | 2 | F | 20131003 | 20150319 | 20140324 | 20150331 | EXP | PHHY2014DE032956 | NOVARTIS | 0.00 | A | M | Y | 0.00000 | 20150331 | N | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100319772 | 10031977 | 1 | PS | CGP 57148B | IMATINIB MESYLATE | 1 | ORAL | 400 MG, QD | 324800 | MG | U | 21588 | 400 | MG | QD | ||||
| 100319772 | 10031977 | 2 | C | RAMIPRIL. | RAMIPRIL | 1 | ORAL | 2.5 MG, QD | D | 0 | 2.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100319772 | 10031977 | 1 | Gastrointestinal stromal tumour |
| 100319772 | 10031977 | 2 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100319772 | 10031977 | HO |
| 100319772 | 10031977 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100319772 | 10031977 | Abdominal pain | |
| 100319772 | 10031977 | Nephrolithiasis | |
| 100319772 | 10031977 | Renal colic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100319772 | 10031977 | 1 | 20110715 | 20140709 | 0 |